STIs Part I: Candidiasis, Trichomoniasis, and Bacterial Vaginosis

The Centers for Disease Control and Prevention just updated guidelines for sexually transmitted infections (previously sexually transmitted diseases) for everything but HIV. In this multi-part series, host Geoff Wall will break down what’s new and what’s changing in practice. The GameChanger Maintenace treatment for recurrent vulvovaginal candidiasis is marginally effective. The standard of care in the treatment of trichomoniasis is now metronidazole for seven days. Current data do not suggest routine treatment of male partners of women with bacterial vaginosis.  Show Segments 00:00 – Introductions 01:20 – STI Guidelines 02:20 – Vaginal Candidiasis  11:12 – Trichomoniasis  19:23 – Bacterial Vaginosis  26:06 – Closing Remarks  Host Geoff Wall, PharmD., BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health All relevant financial relationships have been mitigated. References and Resources CDC Sexually Transmitted Infections Treatment Guidelines, 2021Redeem your CPE or CME.CPE (Pharmacists)  CME (Physicians)Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Join for CPE CreditJoin for CME Credit CE Information Learning Objectives Describe the new recommendations for treatment of candidiasisDiscuss changes in duration of therapy for treatment of trichomoniasisIdentify treatment options for bacterial vaginosis0.05 CEU/0.5 Hr UAN: 0107-0000-22-222-H01-P Initial release date: 05/23/2022 Expiration date: 05/23/2023 Additional CPE and CME details can be found here. Follow CEimpact on Social Media:LinkedInInstagram